BD receives 510(k) clearance for fingerstick blood test sample collection device.

BECTON-Dickinson (Company); MEDICAL equipment; BLOOD testing; UNITED States. Food & Drug Administration; BUSINESS finance

Becton Dickinson (BD) has received 510(k) clearance for a new device called the MiniDraw Capillary Blood Collection System, which allows for blood collection from a fingerstick rather than a vein. This device is slightly larger than its predecessor, the BD Microtainer MAP Microtube, and is approved for use in "ancillary healthcare facilities," such as pharmacies. BD partnered with Babson Diagnostics to develop this system, which will support blood collection for lipid panel, selected chemistry tests, and hemoglobin and hematocrit analyses. The device aims to expand access to blood tests by allowing trained healthcare workers to collect blood at non-traditional sites like pharmacies. This innovation is different from the failed startup Theranos, as BD's device collects more blood for a shorter list of tests and has received FDA clearance. [Extracted from the article]

Copyright of MedTech Dive is the property of Industry Dive and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)